NCT02530476 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- 2 years, 7 months
- Other-event reporting threshold
- 5%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Phase I Group 1 Selinexor + Sorafenib | 4 / 4 | 3 / 4 | 1 / 4 |
| Phase I Group 2 Selinexor + Sorafenib | 3 / 3 | 3 / 3 | 0 / 3 |
| Cohort 1 (FLT3-ITD Inhibitor Failure Cohort) | 6 / 6 | 6 / 7 | 2 / 7 |
| Cohort 2 (FLT3-ITD Inhibitor Naive Cohort) | 3 / 3 | 1 / 3 | 2 / 3 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Acute Kidney Injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Bronchopulmonary Hemorrhage
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Dehydration
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Epistaxis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 6
- num Events
- 5
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Febrile Neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Fever
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Gastrointestinal Disorders Other
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Administration Site Conditions
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Hyponatremia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Vascular disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Hypotension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 3
- num Events
- 3
- term
- Infections
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Acute Kidney Injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Adrenal insufficiency
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 4
- num Events
- 6
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 3
- num Events
- 4
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 7
- num Events
- 4
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Anorexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 4
- num Events
- 3
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Cardiac Disorders
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Confusion
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 4
- num Events
- 3
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 3
- num Events
- 3
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 7
- num Events
- 5
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 3
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 4
- num Events
- 4
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 3
- num Events
- 4
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 7
- num Events
- 5
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Hyperbilirubinemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 4
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 2
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 7
- num Events
- 5
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 2
- term
- Hyponatremia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 7
- num Events
- 4
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Infection Other
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 4
- num Events
- 6
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 7
- num Events
- 3
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Nausea/Vomiting
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 4
- num Events
- 4
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Weakness
Complete source fields
- event Groups
- deaths Num Affected
- 1
- deaths Num At Risk
- 4
- description
- Cohort includes those with FLT3-ITD and -D835 mutated participants with relapsed/refractory AML, including participants who may have been previously exposed to one or more FLT3-inhibitors. Phase I Starting Dose of Sorafenib: 400 mg by mouth twice daily for a 28 day cycle. Phase I Starting Dose of Selinexor: 80 mg by mouth twice weekly for a 28 day cycle. Selinexor: Phase I Starting Dose of Selinexor: 80 mg by mouth twice weekly for a 28 day cycle. Phase II Starting Dose of Selinexor: Maximum tolerated dose from Phase I. Sorafenib: Phase I Starting Dose of Sorafenib: 400 mg by mouth twice daily for a 28 day cycle. Phase II Starting Dose of Sorafenib: Maximum tolerated dose combination from Phase I.
- id
- EG000
- other Num Affected
- 3
- other Num At Risk
- 4
- serious Num Affected
- 4
- serious Num At Risk
- 4
- title
- Phase I Group 1 Selinexor + Sorafenib
- deaths Num Affected
- 0
- deaths Num At Risk
- 3
- description
- Cohort includes those with FLT3-ITD and -D835 mutated participants with relapsed/refractory AML, including participants who may have been previously exposed to one or more FLT3-inhibitors. Phase I Starting Dose of Sorafenib: 400 mg by mouth twice daily for a 28 day cycle. Phase I Starting Dose of Selinexor: 80 mg by mouth twice weekly for a 28 day cycle. Phase I Group 2 received Selinexor 80 mg by mouth twice weekly for a 28 day cycle.
- id
- EG001
- other Num Affected
- 3
- other Num At Risk
- 3
- serious Num Affected
- 3
- serious Num At Risk
- 3
- title
- Phase I Group 2 Selinexor + Sorafenib
- deaths Num Affected
- 2
- deaths Num At Risk
- 7
- description
- Cohort includes those with FLT3-ITD and -D835 mutated relapsed/refractory AML who have failed therapy with up to two prior salvage regimens. Phase II Starting Dose of Sorafenib: Maximum tolerated dose combination from Phase I. Phase II Starting Dose of Selinexor: Maximum tolerated dose from Phase I. Selinexor: Phase I Starting Dose of Selinexor: 80 mg by mouth twice weekly for a 28 day cycle. Phase II Starting Dose of Selinexor: Maximum tolerated dose from Phase I. Sorafenib: Phase I Starting Dose of Sorafenib: 400 mg by mouth twice daily for a 28 day cycle. Phase II Starting Dose of Sorafenib: Maximum tolerated dose combination from Phase I.
- id
- EG002
- other Num Affected
- 6
- other Num At Risk
- 7
- serious Num Affected
- 6
- serious Num At Risk
- 6
- title
- Cohort 1 (FLT3-ITD Inhibitor Failure Cohort)
- deaths Num Affected
- 2
- deaths Num At Risk
- 3
- description
- Cohort includes those with FLT3-ITD and -D835 mutated relapsed/refractory AML who have failed therapy with up to two prior salvage regimens. Phase II Starting Dose of Sorafenib: Maximum tolerated dose combination from Phase I. Phase II Starting Dose of Selinexor: Maximum tolerated dose from Phase I. Selinexor: Phase I Starting Dose of Selinexor: 80 mg by mouth twice weekly for a 28 day cycle. Phase II Starting Dose of Selinexor: Maximum tolerated dose from Phase I. Sorafenib: Phase I Starting Dose of Sorafenib: 400 mg by mouth twice daily for a 28 day cycle. Phase II Starting Dose of Sorafenib: Maximum tolerated dose combination from Phase I.
- id
- EG003
- other Num Affected
- 1
- other Num At Risk
- 3
- serious Num Affected
- 3
- serious Num At Risk
- 3
- title
- Cohort 2 (FLT3-ITD Inhibitor Naive Cohort)
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Acute Kidney Injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Adrenal insufficiency
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 4
- num Events
- 6
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 3
- num Events
- 4
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 7
- num Events
- 4
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Anorexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 4
- num Events
- 3
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 7
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Cardiac Disorders
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Confusion
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 4
- num Events
- 3
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 3
- num Events
- 3
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 7
- num Events
- 5
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 3
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 4
- num Events
- 4
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 3
- num Events
- 4
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 7
- num Events
- 5
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 7
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Hyperbilirubinemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 4
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 2
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 7
- num Events
- 5
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 2
- term
- Hyponatremia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 7
- num Events
- 4
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Infection Other
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 4
- num Events
- 6
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 7
- num Events
- 3
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Nausea/Vomiting
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 4
- num Events
- 4
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 7
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Weakness
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Acute Kidney Injury
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Bronchopulmonary Hemorrhage
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Dehydration
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Epistaxis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 6
- num Events
- 5
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Febrile Neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Fever
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Gastrointestinal Disorders Other
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Administration Site Conditions
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- term
- Hyponatremia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Vascular disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- term
- Hypotension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 3
- num Events
- 3
- term
- Infections
- time Frame
- 2 years, 7 months
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle